45 results
Page 2 of 3
424B5
ggktu6lyrtj9z6 d0yt9
26 Apr 22
Prospectus supplement for primary offering
4:02pm
424B5
j2diiz7mxznvepgd80q
25 Apr 22
Prospectus supplement for primary offering
4:03pm
8-K
EX-99.2
8tq20
25 Apr 22
Nkarta Announces Positive Preliminary Dose Finding Data for Two Lead Engineered Natural Killer Cell Programs
7:52am
8-K
EX-99.1
c9g28ko
25 Apr 22
Nkarta Announces Positive Preliminary Dose Finding Data for Two Lead Engineered Natural Killer Cell Programs
7:52am
8-K
EX-10.1
gedpf qm7
14 Jul 21
Entry into a Material Definitive Agreement
7:07am
DEF 14A
9do34wv zvz
22 Apr 21
Definitive proxy
12:35pm
10-K
euo5ymox
25 Mar 21
Annual report
12:00am
8-K
EX-99.2
8z5hlwnoym
12 Nov 20
Nkarta Reports Third Quarter 2020 Financial Results
4:08pm
10-Q
382gab9js6iqm
20 Aug 20
Quarterly report
4:51pm
424B4
khnpmjflxo0fl32
10 Jul 20
Prospectus supplement with pricing info
9:35pm
S-1/A
y87sytlu9c
2 Jul 20
IPO registration (amended)
5:17pm
CORRESP
z6ugglic2juz2fll10l
29 Jun 20
Correspondence with SEC
12:00am
S-1
t6zq4
19 Jun 20
IPO registration
3:24pm